Showing results (181-190 of 229) with videos related to
Sort By:
Pageof 23
British Journal of Cancer|June 18, 2014
Strategies to diagnose ovarian cancer: new evidence from phase 3 of the multicentre international IOTA studyA Testa, J Kaijser, L Wynants, et al.European Journal of Cancer (Oxford, England : 1990)|May 9, 2003
Phase II study of fotemustine in patients with advanced ovarian carcinoma. A trial of the EORTC Gynecological Cancer GroupM S Aapro, F H van Wijk, M E L van der Burg, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 2011
Stellate ganglion block for the management of hot flashes and sleep disturbances in breast cancer survivors: an uncontrolled experimental study with 24 weeks of follow-upK Haest, A Kumar, B Van Calster, et al.Oncogene|October 10, 2012
miR-141 regulates KEAP1 and modulates cisplatin sensitivity in ovarian cancer cellsM T M van Jaarsveld, J Helleman, A W M Boersma, et al.Journal of Cancer Research and Clinical Oncology|January 20, 2021
Features of durable response and treatment efficacy for capecitabine monotherapy in advanced breast cancer: real-world evidence from a large single-centre cohortS Thijssen, H Wildiers, K Punie, et al.Gynecologic Oncology|May 24, 2001
Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of CancerH C Wagenaar, N Colombo, I Vergote, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 29, 2011
Aromatase inhibitor-induced loss of grip strength is body mass index dependent: hypothesis-generating findings for its pathogenesisA Lintermans, B Van Calster, M Van Hoydonck, et al.Breast Cancer Research and Treatment|January 11, 2007
Body mass index and HER-2 overexpression in breast cancer patients over 50 years of ageT Van Mieghem, K Leunen, N Pochet, et al.Facts, Views & Vision in Obgyn|June 10, 2021
ESGO/ISUOG/IOTA/ESGE Consensus Statement on preoperative diagnosis of ovarian tumoursD Timmerman, F Planchamp, T Bourne, et al.European Journal of Cancer (Oxford, England : 1990)|May 20, 2003
Cisplatin, doxorubicin and ifosfamide in carcinosarcoma of the female genital tract. A phase II study of the European Organization for Research and Treatment of Cancer Gynaecological Cancer Group (EORTC 55923)R E N van Rijswijk, J B Vermorken, N Reed, et al.Pageof 23